Evaluation of the Venous Excess Ultrasound Score (VExUS) After Circulating Volume Modification in Children.
NCT ID: NCT06695546
Last Updated: 2026-01-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
67 participants
OBSERVATIONAL
2024-12-10
2025-06-06
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Estimation of Central Venous Pressure by Echocardiography in Intubated Children in Pediatric Intensive Care
NCT05195424
Ultrasound-guided Peripheral Vascular Access: What Approaches in Paediatrics?
NCT02483507
The Effect of Fluids Flushed in Pediatric Cardiac Catheterization Procedures on Lung Ultrasound Score
NCT04311918
Non-invasive Assessment of the Current State of Hydration in Children by Ultrasound
NCT04463082
Ultrasound Measurement of RIJV in Patients Between 0-2 Years
NCT03604094
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental
Patients over one year of age treated at Toulouse University Hospital and receiving extrarenal purification, bloodletting or vascular filling \> 10 ml/kg.
VExUS evaluation ultrasound
VExUS evaluation by ultrasound will be performed before the filling/bleeding/cleaning procedure, and again after the procedure:
* Inferior vena cava measurement in Time-Motion (TM) mode, 1-2 cm from the right atrial orifice.
* Hepatic venous Doppler measurement in pulsed Doppler mode.
* Renal vein Doppler measurement in pulsed Doppler mode. Each measurement is performed three times consecutively (to average the results), then the ultrasound measurements are compiled into a score according to the degree of doppler severity.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
VExUS evaluation ultrasound
VExUS evaluation by ultrasound will be performed before the filling/bleeding/cleaning procedure, and again after the procedure:
* Inferior vena cava measurement in Time-Motion (TM) mode, 1-2 cm from the right atrial orifice.
* Hepatic venous Doppler measurement in pulsed Doppler mode.
* Renal vein Doppler measurement in pulsed Doppler mode. Each measurement is performed three times consecutively (to average the results), then the ultrasound measurements are compiled into a score according to the degree of doppler severity.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Minors with parental authority.
* Ultrafiltration time \> 6h.
* Curarized patient, known abnormality of the hepatorenal venous network.
* Patient agitated or poor tolerance of the examination.
* Parents under court protection, guardianship or curatorship.
1 Year
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Toulouse
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Montserrat SIERRA COLOMINA, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Toulouse
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Toulouse
Toulouse, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RC31/24/0457
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.